Elsevier

Dermatologic Clinics

Volume 31, Issue 3, July 2013, Pages 405-425
Dermatologic Clinics

Autoinflammatory Pustular Neutrophilic Diseases

https://doi.org/10.1016/j.det.2013.04.001Get rights and content

Section snippets

Key points

  • Deficiency of the interleukin 1 (IL-1) receptor antagonist (DIRA) is an autosomal-recessive autoinflammatory disease characterized by perinatal-onset pustular dermatosis resembling pustular psoriasis, multifocal aseptic osteomyelitis, and periostitis. It can be effectively treated with IL-1 receptor antagonists.

  • Pyogenic arthritis, pyoderma gangrenosum, and acne compose PAPA syndrome, an autosomal-dominant autoinflammatory syndrome caused by mutations in the PSTPIP1 gene.

  • Synovitis, acne,

Deficiency of the interleukin 1 receptor antagonist

In 2009, Goldbach-Mansky and colleagues described an autosomal-recessive autoinflammatory disorder known as deficiency of the interleukin 1 (IL-1) receptor antagonist (DIRA) (Fig. 1).1, 2, 3, 4, 5, 6 DIRA is caused by homozygous loss of function mutations in IL1RN, the gene encoding the IL-1 receptor antagonist. Mutations lead to unopposed IL-1 signaling and resultant uncontrolled life-threatening systemic inflammation. Heterozygous carriers of loss of function mutations in IL1RN seem to be

Deficiency of the IL-36 receptor antagonist, a monogenic form of pustular psoriasis

Although most patients with pustular psoriasis lack a family history of similar disease, several familial cases have been reported, leading to a potential insight into common pathways of pustular skin disease.8, 9, 10, 11, 12, 13, 14, 15 In 2011, Marrakchi and colleagues13 identified inactivating mutations in the IL-36 receptor antagonist (IL-36RN) gene in 9 Tunisian families with an autosomal-recessive form of generalized pustular psoriasis (GPP). This disease, known as deficiency of the IL-36

CARD14-mediated pustular psoriasis

De novo mutations in caspase recruitment domain family member 14 (CARD14) have also been described in a monogenic form of childhood GPP called CARD14-mediated pustular psoriasis (CAMPS).9, 10 CARD14 mutations have also been previously implicated in plaque-type psoriasis and pityriasis rubra pilaris (PRP).9, 10, 17 CARD14 activates NFκB. Activating missense mutations in CARD14 upregulate NFκB, subsequently increasing the transcription of psoriasis-associated chemokines and cytokines, including

Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome

The syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) was coined by Lindor and colleagues in 1997,19 although it was first described in 1975 in a patient with “streaking leukocyte factor.”20 This rare autosomal-dominant autoinflammatory syndrome is caused by mutations in the gene encoding CD2-binding protein 1, also known as proline-serine-threonine-phosphatase-interacting protein 1 (PSTPIP1). Mutations in PSTPIP1 lead to hyperphosphorylation of the protein and subsequent

SAPHO syndrome

Since the 1960s, associations between pustular dermatologic manifestations and osteoarticular manifestations have been reported under various designations, including pustulotic arthro-osteitis, sternocostoclavicular hyperostosis, acne-associated spondyloarthropathy, acquired hyperostosis syndrome, and CRMO. In 1987, Chamot and colleagues37 proposed a unifying syndrome known as SAPHO syndrome. The prevalence of this rare syndrome is estimated to be fewer than 4 in 10,000, with a female

Overview

Genetic advances in monogenic pustular diseases such as DIRA and DITRA have implicated IL-1 family proteins in the development of pustular disease and have led to the successful use of targeted IL-1–blocking agents for these conditions. These insights may provide clues to the pathogenesis of other pustular dermatoses that are believed to have a polygenic cause, such as pustular psoriasis and its variants, and to the potential application of similar targeted therapies for these recalcitrant skin

Summary

Pustular psoriasis and its variants share several overlapping cutaneous, systemic, and osteoarticular features. The classification of these diseases will continue to evolve over the coming years as underlying biological pathways are elucidated, allowing differentiation based on shared mechanisms of disease rather than clinical similarities alone. Recent genetic insights into several rare monogenic forms of pustular disease have already revealed new autoinflammatory pathways and highlight the

First page preview

First page preview
Click to open first page preview

References (222)

  • M. Braun-Falco et al.

    Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)–a new autoinflammatory syndrome distinct from PAPA syndrome

    J Am Acad Dermatol

    (2012)
  • H.A. Majeed et al.

    On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia

    J Pediatr

    (2000)
  • H.A. Majeed et al.

    Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings

    J Pediatr

    (1989)
  • R. Depasquale et al.

    SAPHO: what radiologists should know

    Clin Radiol

    (2012)
  • A.M. Huber et al.

    Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up

    J Pediatr

    (2002)
  • G. Hayem et al.

    SAPHO syndrome: a long-term follow-up study of 120 cases

    Semin Arthritis Rheum

    (1999 Dec)
  • S. Guignard et al.

    Pamidronate treatment in SAPHO syndrome

    Joint Bone Spine

    (2002)
  • M. Van Den Eynde et al.

    Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature

    Gastroenterol Clin Biol

    (2007)
  • B.D. Zelickson et al.

    Generalized pustular psoriasis in childhood. Report of thirteen cases

    J Am Acad Dermatol

    (1991)
  • I. Aksentijevich et al.

    An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

    N Engl J Med

    (2009)
  • A.A. Jesus et al.

    A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil

    Arthritis Rheum

    (2011)
  • D. Levenson

    New inherited immune disorder revealed

    Am J Med Genet A

    (2009)
  • K. Minkis et al.

    Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis

    Arch Dermatol

    (2012)
  • S. Reddy et al.

    An autoinflammatory disease due to homozygous deletion of the IL1RN locus

    N Engl J Med

    (2009)
  • M. Stenerson et al.

    The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist

    Arthritis Rheum

    (2011)
  • C. Schnellbacher et al.

    Deficiency of interleukin-1 receptor antagonist responsive to anakinra

    Pediatr Dermatol

    (2012)
  • M. Landry et al.

    Generalized pustular psoriasis. Observations on the course of the disease in a familial occurrence

    Arch Dermatol

    (1972)
  • S. Lindgren et al.

    Generalized pustular psoriasis. A report on thirteen patients

    Acta Derm Venereol

    (1976)
  • S. Marrakchi et al.

    Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

    N Engl J Med

    (2011)
  • O.Y. Oumeish et al.

    Some aspects of impetigo herpetiformis

    Arch Dermatol

    (1982)
  • K. Sugiura et al.

    A novel IL36RN/IL1F5 homozygous nonsense mutation, p. Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis

    Br J Dermatol

    (2012)
  • N.C. Habal et al.

    Pathogenesis study of infantile-onset, severe pustular psoriasis reveals a de novo mutation in CARD14 causing psoriasis which responds clinically to IL-12/23 blocking treatment with ustekinumab [abstract]

    Arthritis Rheum

    (2011)
  • J.C. Jacobs et al.

    “Streaking leukocyte factor,” arthritis, and pyoderma gangrenosum

    Pediatrics

    (1975)
  • A.L. Waite et al.

    Pyrin modulates the intracellular distribution of PSTPIP1

    PLoS One

    (2009)
  • A.P. Demidowich et al.

    Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)

    Arthritis Rheum

    (2012)
  • N.G. Shoham et al.

    Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway

    Proc Natl Acad Sci U S A

    (2003)
  • M.A. Schellevis et al.

    Variable expression and treatment of PAPA syndrome

    Ann Rheum Dis

    (2011)
  • M. Brenner et al.

    Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra

    Br J Dermatol

    (2009)
  • M.P. Dierselhuis et al.

    Anakinra for flares of pyogenic arthritis in PAPA syndrome

    Rheumatology (Oxford)

    (2005)
  • B. Tallon et al.

    Peculiarities of PAPA syndrome

    Rheumatology

    (2006)
  • C.A. Wise et al.

    Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder

    Hum Mol Genet

    (2002)
  • E.J. Smith et al.

    Clinical, molecular, and genetic characteristics of PAPA syndrome: a review

    Curr Genomics

    (2010)
  • D.S. Stichweh et al.

    Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome

    Pediatr Dermatol

    (2005)
  • N.D. Tofteland et al.

    Clinical efficacy of etanercept for treatment of PAPA syndrome

    J Clin Rheumatol

    (2010)
  • A.M. Chamot et al.

    Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases

    Rev Rhum Mal Osteoartic

    (1987)
  • A. Giedion et al.

    Subacute and chronic “symmetrical” osteomyelitis

    Ann Radiol (Paris)

    (1972)
  • H.A. Majeed et al.

    The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review

    Eur J Pediatr

    (2001)
  • P.J. Ferguson et al.

    Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)

    J Med Genet

    (2005)
  • J.W. Earwaker et al.

    SAPHO: syndrome or concept? Imaging findings

    Skeletal Radiol

    (2003)
  • B.C. Beretta-Piccoli et al.

    Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature

    Eur J Pediatr

    (2000)
  • Cited by (0)

    Disclosures: None.

    View full text